Main content of this page

Anchor links to the different areas of information in this page:

You are here: MEDICA Portal. MEDICA Magazine. Alzheimer's.

Public Health & Associations

Public Health & Associations

News on public health research and national as well as international health policies. Edited by MEDICA.de and several associations.

 
 

Neurology: New Enzyme to Fight Alzheimer's Disease

( Source: MEDICA.de )

[19/09/2012] An enzyme that could represent a powerful new tool for combating Alzheimer's disease has been discovered by researchers at Mayo Clinic in Florida. The enzyme — known as BACE2 — destroys beta-amyloid, a toxic protein fragment that litters the brains of patients who have the disease.Neurology: New Enzyme to Fight Alzheimer's Disease - Read more

World Alzheimer’s Day

( Source: MEDICA.de )

[19/09/2012] Dementia diseases affect more and more people - there are currently about 35 million patients worldwide. By 2050 the number will rise to an estimated 115 million. In order to raise attention for the situation of Alzheimer's patients, every year on 21 September, the World Alzheimer's Day takes place.World Alzheimer’s Day - Read more

Diabetes Drug: Could Help Fight Alzheimer's Disease?

( Source: MEDICA.de )

[17/09/2012] A drug designed for diabetes sufferers could have the potential to treat neurodegenerative diseases like Alzheimer’s, a study by scientists at the University of Ulster has revealed. Type II diabetes is a known risk factor for Alzheimer’s and it is thought that impaired insulin signalling in the brain could damage nerve cells and contribute to the disease.Diabetes Drug: Could Help Fight Alzheimer's Disease? - Read more

Alzheimer's Patients: Delirium and Long-term Cognitive Decline

( Source: MEDICA.de )

[21/08/2012] Patients with Alzheimer's disease who suffered episodes of delirium while hospitalized had a sharply increased rate of mental decline for up to five years after being hospitalized compared to those who did not have any such episodes, according to a study by researchers at the Institute for Aging Research at Hebrew SeniorLife.Alzheimer's Patients: Delirium and Long-term Cognitive Decline - Read more

Dementia: Autoantibodies Damage Blood Vessels in The Brain

( Source: MEDICA.de )

[01/08/2012] The presence of specific autoantibodies of the immune system is associated with blood vessel damage in the brain. These findings were made by researchers of the Max Delbrück Center for Molecular Medicine (MDC) Berlin, Germany, in studies on a rat model.Dementia: Autoantibodies Damage Blood Vessels in The Brain - Read more

Drugs Ferry: ”We are not limited to one active ingredient group or one active ingredient“

( Source: MEDICA.de )

[08/05/2012] Drugs that treat brain diseases such as Alzheimer’s disease or multiple sclerosis are most effective directly where they are needed – in the brain. Unfortunately, it is difficult to develop drugs that are capable of getting there specifically, since the so-called blood-brain barrier prevents this from happening. However, now a team led by Doctor Heiko Manninga succeeded in doing precisely that. Drugs Ferry: ”We are not limited to one active ingredient group or one active ingredient“ - Read more

Brain: New Understanding of Alzheimer's Trigger

( Source: MEDICA.de )

[07/05/2012] A highly toxic beta-amyloid – a protein that exists in the brains of Alzheimer's disease victims – has been found to greatly increase the toxicity of other more common and less toxic beta-amyloids, serving as a possible "trigger" for the advent and development of Alzheimer's, researchers at the University of Virginia have discovered.Brain: New Understanding of Alzheimer's Trigger - Read more

Alzheimer's Disease: Single-neuron Observations Mark Steps

( Source: MEDICA.de )

[26/04/2012] Studying a mouse model of Alzheimer's disease, neuroscientists at the Technische Universitaet Muenchen (TUM), Germany, have observed correlations between increases in both soluble and plaque-forming beta-amyloid – a protein implicated in the disease process – and dysfunctional developments on several levels: individual cortical neurons, neuronal circuits, sensory cognition, and behaviour.Alzheimer's Disease: Single-neuron Observations Mark Steps - Read more

Bipolar Disorder: Body Clocks May Hold Key for Treatment

( Source: MEDICA.de )

[14/03/2012] Scientists have gained insight into why lithium salts are effective at treating bipolar disorder in what could lead to more targeted therapies with fewer side-effects.Bipolar Disorder: Body Clocks May Hold Key for Treatment - Read more

Neurodegenerative Disease: View on Causal Mechanism in ALS

( Source: MEDICA.de )

[01/03/2012] In a study Munich-based researchers refute a widely accepted hypothesis about a causative step in neurodegenerative conditions. These results deal specifically with animal models of human amyotrophic lateral sclerosis (ALS, aka Lou Gehrig's disease) but also raise questions for research on other neurodegenerative diseases, such as Alzheimer's or Huntington's disease.Neurodegenerative Disease: View on Causal Mechanism in ALS - Read more